Health
Nanoparticle based shot could boost efficacy, accelerate production of seasonal flu vaccines – BioPharma-Reporter.com
Seasonal flu vaccines typically work 40-60% of the time, according to the US Centers for Disease Control and Prevention (CDC). An experimental recombinant protein…
Key to the vaccine’s success is a liposome the developers created called cobalt-porphyrin-phospholipid, or CoPoP. They are tiny spherical sacs, which are small enough to be considered nanoparticles, and they form the backbone of the vaccine platform.
Described in a study published on May 24 by the Proceedings of the National Academy of Science, the experimental vaccine has reportedly proven effective in preclinical studies.
The results are very encouraging, says the study’s senior author, Jonathan…
-
General23 hours agoNRLW Sunday: Brisbane Broncos hammer Newcastle Knights, Cronulla Sharks move to third on ladder
-
General12 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Noosa News12 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General15 hours agoFirst home buyers score early access to deposit scheme